Advertisement
Original article| Volume 61, ISSUE 9, P1090-1099, May 01, 2007

Download started.

Ok

Exaggerated 5-HT1A but Normal 5-HT2A Receptor Activity in Individuals Ill with Anorexia Nervosa

  • Ursula F. Bailer
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania

    Department of General Psychiatry, Medical University of Vienna, University Hospital of Psychiatry, Vienna, Austria
    Search for articles by this author
  • Guido K. Frank
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania

    Department of Child and Adolescent Psychiatry, School of Medicine, University of California, San Diego, California
    Search for articles by this author
  • Shannan E. Henry
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania

    Department of Radiology, School of Medicine, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Julie C. Price
    Affiliations
    Department of Radiology, School of Medicine, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Carolyn C. Meltzer
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania

    Department of Neurology, School of Medicine, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pennsylvania

    Departments of Radiology and Neurology, Emory School of Medicine, Atlanta, Georgia
    Search for articles by this author
  • Chester A. Mathis
    Affiliations
    Department of Radiology, School of Medicine, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Angela Wagner
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania

    Department of Child and Adolescent Psychiatry, J.W. Goethe University of Frankfurt/Main, Frankfurt/Main, Germany.
    Search for articles by this author
  • Laura Thornton
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania
    Search for articles by this author
  • Jessica Hoge
    Affiliations
    Department of Radiology, School of Medicine, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Scott K. Ziolko
    Affiliations
    Department of Radiology, School of Medicine, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Carl R. Becker
    Affiliations
    Department of Radiology, School of Medicine, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Claire W. McConaha
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania
    Search for articles by this author
  • Walter H. Kaye
    Correspondence
    Address reprint requests to Walter H. Kaye, M.D., Western Psychiatric Institute and Clinic, University of Pittsburgh, Iroquois Building, Suite 600, 3811 O’Hara Street Pittsburgh, PA 15213
    Affiliations
    Department of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine, Pittsburgh, University of Pittsburgh, Pennsylvania
    Search for articles by this author

      Background

      Many studies have found disturbances of serotonin (5-HT) activity in anorexia nervosa (AN). Because little is known about 5-HT receptor function in AN, positron emission tomography (PET) imaging with 5-HT receptor-specific radioligands was used to characterize 5-HT1A and 5-HT2A receptors.

      Methods

      Fifteen women ill with AN (ILL AN) were compared with 29 healthy control women (CW); PET and [11C]WAY100635 were used to assess binding potential (BP) of the 5-HT1A receptor, and [18F]altanserin was used to assess postsynaptic 5-HT2A receptor BP. [15O] water and PET were used to assess cerebral blood flow.

      Results

      The ILL AN women had a highly significant (30%–70%) increase in [11C]WAY100635 BP in prefrontal and lateral orbital frontal regions, mesial and lateral temporal lobes, parietal cortex, and dorsal raphe nuclei compared with CW. The [18F]altanserin BP was normal in ILL AN but was positively and significantly related to harm avoidance in suprapragenual cingulate, frontal, and parietal regions. Cerebral blood flow was normal in ILL AN women.

      Conclusions

      Increased activity of 5-HT1A receptor activity may help explain poor response to 5-HT medication in ILL AN. This study extends data suggesting that 5-HT function, and, specifically, the 5-HT2A receptor, is related to anxiety in AN.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Amargos-Bosch M.
        • Bortolozzi A.
        • Puig M.
        • Serrats J.
        • Adell A.
        • Celada P.
        • et al.
        Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex.
        Cereb Cortex. 2004; 14: 281-299
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC1994
        • Arango V.
        • Underwood M.D.
        • Gubbi A.V.
        • Mann J.J.
        Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims.
        Brain Res. 1995; 688: 121-133
        • Attia E.
        • Haiman C.
        • Walsh B.T.
        • Flater S.R.
        Does fluoxetine augment the inpatient treatment of anorexia nervosa?.
        Am J Psychiatry. 1998; 155: 548-551
        • Audenaert K.
        • Van Laere K.
        • Dumont F.
        • Vervaet M.
        • Goethals I.
        • Slegers G.
        • et al.
        Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
        J Nucl Med. 2003; 44: 163-169
        • Bailer U.F.
        • Frank G.K.
        • Henry S.E.
        • Price J.C.
        • Meltzer C.C.
        • Weissfeld L.
        • et al.
        Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11C]WAY100635.
        Arch Gen Psychiatry. 2005; 62: 1032
        • Bailer U.F.
        • Price J.C.
        • Meltzer C.C.
        • Mathis C.A.
        • Frank G.K.
        • Weissfeld L.
        • et al.
        Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa: Relationships to harm avoidance and drive for thinness.
        Neuropsychopharmacology. 2004; 29: 1143-1155
        • Barbarich N.C.
        • McConaha C.W.
        • Halmi K.A.
        • Gendall K.
        • Sunday S.R.
        • Gaskill J.
        • et al.
        Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.
        Int J Eat Disord. 2004; 35: 10-15
        • Barr L.C.
        • Goodman W.K.
        • Price L.H.
        • McDougle C.J.
        • Charney D.S.
        The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies.
        J Clin Psychiatry. 1992; 53: 17-28
        • Beck A.T.
        • Ward M.
        • Mendelson M.
        • Mock J.
        • Erbaugh J.
        An inventory for measuring depression.
        Arch Gen Psychiatry. 1961; 4: 53-63
        • Benjamini Y.
        • Hochberg Y.
        Controlling the false discovery rate: A practical and powerful approach to multiple testing.
        J Royal Statist Soc B. 1995; 57: 289-300
        • Blier P.
        • de Montigny C.
        Serotonin and drug-induced therapeutic responses in major depression, obsessive–compulsive and panic disorders.
        Neuropsychopharmacology. 1999; 21: 91S-98S
        • Blundell J.E.
        Serotonin and appetite.
        Neuropharmacology. 1984; 23: 1537-1551
        • Bonhomme N.
        • Esposito E.
        Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review.
        J Clin Psychopharmacol. 1998; 18: 447-454
        • Brewerton T.D.
        • Brandt H.A.
        • Lessem M.D.
        • Murphy D.L.
        • Jimerson D.C.
        Serotonin in eating disorders.
        in: Coccaro E.F. Murphy D.L. Serotonin in Major Psychiatric Disorders. vol. 21. American Psychiatric Press, Washington, DC1990: 155-184
        • Brewerton T.D.
        • Jimerson D.C.
        Studies of serotonin function in anorexia nervosa.
        Psychiatry Res. 1996; 62: 31-42
        • Bulik C.M.
        • Sullivan P.F.
        • Kendler K.S.
        Heritability of binge-eating and broadly defined bulimia nervosa.
        Biol Psychiatry. 1998; 44: 1210-1218
        • Burnet P.W.
        • Eastwood S.L.
        • Harrison P.J.
        [3H]WAY–100635 for 5-HT1A receptor autoradiography in human brain: A comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
        Neurochem Int. 1997; 30: 565-574
        • Carrasco G.
        • Barker S.
        • Zhang Y.
        • Damjanoska K.
        • Sullivan N.
        • Garcia F.
        • et al.
        Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: Possible role in desensitization of 5-hydroxytryptamine1A receptors.
        Neuroscience. 2004; 127: 261-267
        • Cervo L.
        • Mocaer E.
        • Bertaglia A.
        • Samanin R.
        Roles of 5-HT1A receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller–Seifter conflict model.
        Neuropharmacology. 2000; 39: 1037-1043
        • Chowdhury U.
        • Gordon I.
        • Lask B.
        • Watkins B.
        • Watt H.
        • Christie D.
        Early-onset anorexia nervosa: Is there evidence of limbic system imbalance?.
        Int J Eat Disord. 2003; 33: 388-396
        • Cloninger C.R.
        A systematic method for clinical description and classification of personality variants.
        Arch Gen Psychiatry. 1987; 44: 573-588
        • De Vry J.
        • Schreiber R.
        Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: Possible mechanisms of action.
        Neurosci Biobehav Rev. 2000; 24: 341-353
        • Drevets W.C.
        • Frank E.
        • Price J.C.
        • Kupfer D.J.
        • Greer P.J.
        • Mathis C.
        Serotonin type–1A receptor imaging in depression.
        Nucl Med Biol. 2000; 27: 499-507
        • Ellison A.R.
        • Fong J.
        Neuroimaging in eating disorders.
        in: Hoek H.W. Treasure J.L. Katzman M.A. Neurobiology in the Treatment of Eating Disorders. Wiley, Chichester, England1998: 255-269
        • Ferguson C.P.
        • La Via M.C.
        • Crossan P.J.
        • Kaye W.H.
        Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?.
        Int J Eat Disord. 1999; 25: 11-17
        • First M.B.
        • Gibbon M.
        • Spitzer R.L.
        • Williams J.B.W.
        Users guide for the structured clinical interview for DSM-IV Axis I disorders—research version (SCID-I, ver. 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York1996
        • First M.B.
        • Gibbon M.
        • Spitzer R.L.
        • Williams J.B.W.
        • Benjamin L.S.
        User’s guide for the structured clinical interview for DSM-IV Axis II personal disorders (SCID-II). American Psychiatric Press, Washington, DC1997
        • Frank G.K.
        • Kaye W.H.
        • Greer P.
        • Meltzer C.C.
        • Price J.C.
        Regional cerebral blood flow after recovery from bulimia nervosa.
        Psychiatry Res. 2000; 100: 31-39
        • Frank G.K.
        • Kaye W.H.
        • Meltzer C.C.
        • Price J.C.
        • Greer P.
        • McConaha C.
        • Skovira K.
        Reduced 5-HT2A receptor binding after recovery from anorexia nervosa.
        Biol Psychiatry. 2002; 52: 896-906
        • Frost R.O.
        • Marten P.
        • Lahart C.
        • Rosenblate R.
        The dimensions of perfectionism.
        Cogn Ther Res. 1990; 14: 449-468
        • Garner D.M.
        Eating Disorder Inventory—2 Professional Manual. Psychological Assessment Resources, Lutz, FL1990
        • Goldbloom D.S.
        • Hicks L.K.
        • Garfinkel P.E.
        Platelet serotonin uptake in bulimia nervosa.
        Biol Psychiatry. 1990; 28: 644-647
        • Goodman W.K.
        • Price L.H.
        • Rasmussen S.A.
        • Mazure C.
        • Delgado P.
        • Heninger G.R.
        • Charney D.S.
        The Yale–Brown Obsessive Compulsive Scale.
        Arch Gen Psychiatry. 1989; 46: 1012-1016
        • Goodman W.K.
        • Price L.H.
        • Rasmussen S.A.
        • Mazure C.
        • Fleischmann R.L.
        • Hill C.L.
        • et al.
        The Yale–Brown Obsessive Compulsive Scale.
        Arch Gen Psychiatry. 1989; 46: 1006-1011
        • Goodwin G.M.
        • Shapiro C.M.
        • Bennie J.
        • Dick H.
        • Carroll S.
        • Fink G.
        The neuroendocrine responses and psychological effects of infusion of L- tryptophan in anorexia nervosa.
        Psychol Med. 1989; 19: 857-864
        • Gordon C.M.
        • Dougherty D.D.
        • Fischman A.J.
        • Emans S.J.
        • Grace E.
        • Lamm R.
        • et al.
        Neural substrates of anorexia nervosa: A behavioral challenge study with positron emission tomography.
        J Pediatr. 2001; 139: 51-57
        • Gordon I.
        • Lask B.
        • Bryant-Waugh R.
        • Christie D.
        • Timimi S.
        Childhood-onset anorexia nervosa: Towards identifying a biological substrate.
        Int J Eat Disord. 1997; 22: 159-165
        • Hadigan C.M.
        • Walsh B.T.
        • Buttinger C.
        • Hollander E.
        Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
        Biol Psychiatry. 1995; 37: 504-511
        • Haleem D.J.
        • Haider S.
        Food restriction decreases serotonin and its synthesis rate in the hypothalamus.
        Neuroreport. 1996; 7: 1153-1156
        • Herzog D.B.
        • Field A.E.
        • Keller M.B.
        • West J.C.
        • Robbins W.M.
        • Staley J.
        • Colditz G.A.
        Subtyping eating disorders: Is it justified?.
        J Am Acad Child Adolesc Psychiatry. 1996; 35: 928-936
        • Higley J.D.
        • Linnoila M.
        Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior.
        Ann N Y Acad Sci. 1997; 836: 39-56
        • Huether G.
        • Zhou D.
        • Ruther E.
        Long-term modulation of presynaptic 5-HT-output: Experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density.
        J Neural Transm Gen Sect. 1997; 104: 993-1004
        • Jimerson D.C.
        • Wolfe B.E.
        • Metzger E.D.
        • Finkelstein D.M.
        • Cooper T.B.
        • Levine J.M.
        Decreased serotonin function in bulimia nervosa.
        Arch Gen Psychiatry. 1997; 54: 529-534
        • Kang M.
        • Park C.
        • Ahn H.
        • Huh Y.
        Ectopic expression of serotonin-positive neurons in the hypothalamus associated with a significant serotonin decrease in the midbrain of food restricted rats.
        Neurosci Lett. 2001; 314: 25-28
        • Kaye W.H.
        Anorexia and bulimia nervosa, obsessional behavior, and serotonin.
        in: Kaye W.H. Jimerson D.C. Eating Disorders. vol. 3. Balliere’s Tindell, London1997: 319-337
        • Kaye W.H.
        • Gwirtsman H.E.
        • George D.T.
        • Ebert M.H.
        Altered serotonin activity in anorexia nervosa after long-term weight restoration.
        Arch Gen Psychiatry. 1991; 48: 556-562
        • Kaye W.H.
        • Gwirtsman H.E.
        • George D.T.
        • Jimerson D.C.
        • Ebert M.H.
        CSF 5-HIAA concentrations in anorexia nervosa: Reduced values in underweight subjects normalize after weight gain.
        Biol Psychiatry. 1988; 23: 102-105
        • Kaye W.H.
        • Nagata T.
        • Weltzin T.E.
        • Hsu L.K.
        • Sokol M.S.
        • McConaha C.
        • et al.
        Double-blind placebo-controlled administration of fluoxetine in restricting—and restricting-purging-type anorexia nervosa.
        Biol Psychiatry. 2001; 49: 644-652
        • Kaye W.H.
        • Walsh T.W.
        Psychopharmacology of eating disorders.
        in: Davis K. Charney D. Coyle J. Nemeroff C. Neuropsychopharmacology The Fifth Generation of Progress. Lippincott Williams & Wilkins, Philadelphia2002: 1675-1683
        • Klump K.L.
        • Miller K.B.
        • Keel P.K.
        • McGue M.
        • Iacono W.G.
        Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample.
        Psychol Med. 2001; 31: 737-740
        • Krebs-Thomson K.
        • Geyer M.A.
        Evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in rats.
        Psychopharmacology (Berl). 1998; 140: 69-74
        • Kuruoglu A.C.
        • Kapucu O.
        • Atasever T.
        • Arikan Z.
        • Isik E.
        • Unlu M.
        Technetium-99m-HMPAO brain SPECT in anorexia nervosa.
        J Nucl Med. 1998; 39: 304-306
        • Lammertsma A.A.
        Radioligand studies: Imaging and quantitative analysis.
        Eur Neuropsychopharmacol. 2002; 12: 513-516
        • Leibowitz S.F.
        • Shor-Posner G.
        Brain serotonin and eating behavior.
        Appetite. 1986; 7: 1-14
        • Lemaire C.
        • Cantineau R.
        • Guillaume M.
        • Plenevaux A.
        • Christiaens L.
        Fluorine-18-altanserin: A radioligand for the study of serotonin receptors with PET: Radiolabeling and in vivo biologic behavior in rats.
        J Nucl Med. 1991; 32: 2266-2272
        • Levitan R.D.
        • Kaplan A.S.
        • Joffe R.T.
        • Levitt A.J.
        • Brown G.M.
        Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
        Arch Gen Psychiatry. 1997; 54: 521-527
        • Logan J.
        • Fowler J.
        • Volkow N.
        • Ding Y.
        • Wang G.
        • Alexoff D.
        A strategy for removing the bias in the graphical analysis method.
        J Cereb Blood Flow Metab. 2001; 21: 307-320
        • Logan J.
        • Fowler J.S.
        • Volkow N.D.
        • Wolf A.P.
        • Dewey S.L.
        • Schlyer D.J.
        • et al.
        Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.
        J Cereb Blood Flow Metab. 1990; 10: 740-747
        • Lucki I.
        The spectrum of behaviors influenced by serotonin.
        Biol Psychiatry. 1998; 44: 151-162
        • Mann J.J.
        Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior.
        Neuropsychopharmacology. 1999; 21: 99S-105S
        • Matsubara S.
        • Arora R.C.
        • Meltzer H.Y.
        Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims.
        J Neural Transm Gen Section. 1991; 85: 181-194
        • Mazure C.M.
        • Halmi K.A.
        • Sunday S.R.
        • Romano S.J.
        • Einhorn A.M.
        The Yale–Brown–Cornell Eating Disorder Scale: Development, use, reliability and validity.
        J Psych Res. 1994; 28: 425-445
        • McCarron J.A.
        • Turton D.
        • Pike V.W.
        • Poole K.
        Remotely-controlled production of the 5-HT1A receptor radioligand, [carbonyl-11C]WAY–100635, via 11C-carboxylation of an immobilized grignard reagent.
        J Labelled Compounds Radiopharm. 1996; 38: 941-953
        • Meltzer C.
        • Drevets W.
        • Price J.
        • Mathis C.
        • Lopresti B.
        • Greer P.
        • et al.
        Gender-specific aging effects on the serotonin 1A receptor.
        Brain Res. 2001; 895: 9-17
        • Meltzer C.C.
        • Kinaham P.
        • Nichols T.E.
        • Greer P.J.
        • Comtat C.
        • Cantwell M.N.
        • Price J.
        Comparative evaluation of MR-based partial-volume correction schemes for PET.
        J Nucl Med. 1999; 40: 2053-2065
        • Meltzer C.C.
        • Price J.
        • Mathis C.
        • Butters M.
        • Ziolko S.
        • Moses-Kolko E.
        • et al.
        Serotonin 1A receptor binding and treatment responses in late-life depression.
        Neuropsychopharmacology. 2004; 29: 2258-2265
        • Meltzer C.C.
        • Zubieta J.K.
        • Links J.M.
        • Brakeman P.
        • Stumpf M.J.
        • Frost J.J.
        MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution.
        J Cereb Blood Flow Metab. 1996; 16: 650-657
        • Moresco F.M.
        • Dieci M.
        • Vita A.
        • Messa C.
        • Gobbo C.
        • Galli L.
        • et al.
        In vivo serotonin 5HT2A receptor binding and personality traits in healthy subjects: A positron emission tomography study.
        Neuroimage. 2002; 17: 1470-1478
        • Moses E.L.
        • Drevets W.C.
        • Smith G.
        • Mathias C.A.
        • Kalro B.N.
        • Butters M.A.
        • et al.
        Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: A PET study.
        Biol Psychiatry. 2000; 15: 854-860
        • Moses-Kolko E.
        • Berga S.
        • Greer P.
        • Smith G.
        • Cidis Meltzer C.
        • Drevets W.
        Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women.
        Fertil Steril. 2003; 80: 554-559
        • O’Dwyer A.M.
        • Lucey J.V.
        • Russell G.F.
        Serotonin activity in anorexia nervosa after long-term weight restoration: Response to D-fenfluramine challenge.
        Psychol Med. 1996; 26: 353-359
        • Olivier B.
        • Pattij T.
        • Wood S.
        • Oosting R.
        • Sarnyai Z.
        • Toth M.
        The 5-HT1A receptor knockout mouse and anxiety.
        Behav Pharmacol. 2001; 12: 439-450
        • Parsey R.V.
        • Slifstein M.
        • Hwang D.R.
        • Abi-Dargham A.
        • Simpson N.
        • Mawlawi O.
        • et al.
        Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY–100635 in humans: Comparison of arterial and reference tissue input functions.
        J Cereb Blood Flow Metab. 2000; 20: 1111-1133
        • Price J.
        • Xu L.
        • Mazumdar S.
        • Meltzer C.
        • Drevets W.
        • Mathis C.
        • et al.
        Impact of graphical analysis bias on group comparisons of regional [carbonyl-11C]WAY binding potential measures.
        Neuroimage. 2002; 16: S72
        • Price J.C.
        • Drevets W.C.
        • Ruszkiewicz J.
        • Greer P.J.
        • Villemagne V.L.
        • Xu L.
        • et al.
        Sequential [15O]water PET studies in baboons: Pre- and post-amphetamine.
        J Nucl Med. 2002; 43: 1090-1100
        • Price J.C.
        • LoPresti B.J.
        • Mason N.S.
        • Holt C.S.
        • Huang Y.
        • Mathis C.
        Analyses of [18F]altanserin bolus injection PET data I: Consideration of radiolabeled metabolites in baboons.
        Synapse. 2001; 41: 1-10
        • Price J.C.
        • Lopresti B.J.
        • Meltzer C.C.
        • Smith G.S.
        • Mason N.S.
        • Huang Y.
        • et al.
        Analyses of [18F]altanserin bolus injection PET data.
        Synapse. 2001; 41: 11-21
        • Rastam M.
        • Bjure J.
        • Vestergren E.
        • Uvebrant P.
        • Gillberg I.C.
        • Wentz E.
        • Gillberg C.
        Regional cerebral blood flow in weight-restored anorexia nervosa: A preliminary study.
        Dev Med Child Neurol. 2001; 43: 239-242
        • Rupprecht R.
        Neuroactive steroids: Mechanisms of action and neuropsychopharmacological properties.
        Psychoneuroendocrinology. 2003; 28: 139-168
        • Santana N.
        • Bortolozzi A.
        • Serrats J.
        • Mengod G.
        • Artigas F.
        Expression of serotonin1A and serotonin 2A receptor in pyramidal and GABAergic neurons of the rat prefrontal cortex.
        Cereb Cortex. 2004; 14: 1100-1109
        • Saudou F.
        • Hen R.
        5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates.
        Neurochem Int. 1994; 25: 503-532
        • Simansky K.J.
        Serotonergic control of the organization of feeding and satiety.
        Behav Brain Res. 1996; 73: 37-42
        • Soubrie P.
        Reconciling the role of central serotonin neurons in human and animal behavior.
        Behav Brain Sci. 1986; 9: 319
        • Spielberger C.D.
        • Gorsuch R.L.
        • Lushene R.E.
        STAI Manual for the State Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA1970
        • Steiger H.
        • Gauvin L.
        • Israel M.
        • Koerner N.
        • Ng Ying Kin N.M.
        • Paris J.
        • Young S.N.
        Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa.
        Arch Gen Psychiatry. 2001; 58: 837-843
        • Steiger H.
        • Koerner N.
        • Engelberg M.J.
        • Israel M.
        • Ng Ying Kin N.M.
        • Young S.N.
        Self-destructiveness and serotonin function in bulimia nervosa.
        Psychiatry Res. 2001; 103: 15-26
        • Steiger H.
        • Young S.N.
        • Kin N.M.
        • Koerner N.
        • Israel M.
        • Lageix P.
        • Paris J.
        Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa.
        Psychol Med. 2001; 31: 85-95
        • Stockmeier C.A.
        Neurobiology of serotonin in depression and suicide.
        Ann N Y Acad Sci. 1997; 836: 220-232
        • Strober M.
        • Pataki C.
        • Freeman R.
        • DeAntonio M.
        No effect of adjunctive fluoxetine on eating behavior or weight phobia during the inpatient treatment of anorexia nervosa: An historical case–control study.
        J Child Adolesc Psychopharmacol. 1999; 9: 195-201
        • Sullivan P.F.
        • Bulik C.M.
        • Fear J.L.
        • Pickering A.
        Outcome of anorexia nervosa: A case–control study.
        Am J Psychiatry. 1998; 155: 939-946
        • Sunday S.R.
        • Halmi K.A.
        • Einhorn A.
        The Yale–Brown–Cornell Eating Disorder Scale: A new scale to assess eating disorder symptomatology.
        Int J Eat Disord. 1995; 18: 237-245
        • Takano A.
        • Shiga T.
        • Kitagawa N.
        • Koyama T.
        • Katoh C.
        • Tsukamoto E.
        • Tamaki N.
        Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT.
        Psychiatry Res Neuroimag. 2001; 107: 45-50
        • van Heeringen C.
        • Audenaert K.
        • Van Laere K.
        • Dumont F.
        • Slegers G.
        • Mertens J.
        • Dierckx R.A.
        Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide.
        J Affect Disord. 2003; 74: 149-158
        • Vollenweider F.
        • Vontobel P.
        • Hell D.
        • Leenders K.
        5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—a PET study with [11C]raclopride.
        Neuropsychopharmacology. 1999; 20: 424-433
        • Wagner A.
        • Barbarich N.C.
        • Frank G.K.
        • Bailer U.F.
        • Henry S.E.
        • Plotnicov K.
        • et al.
        Personality traits after recovery from eating disorders, do subtypes differ?.
        Int J Eat Disord. 2006; 39: 276-284
        • Walsh B.T.
        • Devlin M.J.
        Eating disorders: Progress and problems.
        Science. 1998; 280: 1387-1390
        • Ward A.
        • Brown N.
        • Lightman S.
        • Campbell I.C.
        • Treasure J.
        Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa.
        Br J Psychiatry. 1998; 172: 351-358
        • Wihlback A.
        • Sundstrom Poromaa I.
        • Bixo M.
        • Allard P.
        • Mjorndal T.
        • Spigset O.
        Influence of menstrual cycle on platelet serotonin uptake site and serotonin 2A receptor binding.
        Psychoneuroendocrinology. 2004; 29: 757-766
        • Wolfe B.E.
        • Metzger E.D.
        • Jimerson D.C.
        Research update on serotonin function in bulimia nervosa and anorexia nervosa.
        Psychopharmacol Bull. 1997; 33: 345-354
        • Young S.N.
        • Gauthier S.
        Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid.
        J Neurol Neurosurg Psychiatry. 1981; 44: 323-327